BPCA
XBI icon

Bank Pictet & Cie (Asia)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bank Pictet & Cie (Asia)’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,900
Closed -$215K – 90
2022
Q2 		$215K Buy
+2,900
New +$218K 0.07% 88

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Bank Pictet & Cie (Asia)'s XBI Position: Q3 2022 in Review

Bank Pictet & Cie (Asia) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 2,900 shares — an estimated $215K sold.

Bank Pictet & Cie (Asia) first reported a position in XBI in Q2 2022 and held it in 1 quarter. The position peaked at $215K in Q2 2022. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

  • Bank Pictet & Cie (Asia) reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
  • Bank Pictet & Cie (Asia) sold 2,900 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $215K.
  • Bank Pictet & Cie (Asia) first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 1 quarter.
  • Bank Pictet & Cie (Asia)'s State Street SPDR S&P Biotech ETF position peaked at $215K in Q2 2022.
  • 704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Bank Pictet & Cie (Asia)'s 13F filing for Q3 2022, filed 4 Nov 2022.